NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 201 filers reported holding NOVOCURE LTD in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $214,000 | -25.7% | 1,998 | -9.1% | 0.00% | – |
| Q3 2021 | $288,000 | -42.2% | 2,199 | -2.2% | 0.00% | -100.0% |
| Q2 2021 | $498,000 | +65.4% | 2,248 | -1.3% | 0.00% | – |
| Q1 2021 | $301,000 | -23.8% | 2,278 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $395,000 | +53.7% | 2,278 | -1.5% | 0.00% | – |
| Q3 2020 | $257,000 | -90.1% | 2,312 | -94.0% | 0.00% | -100.0% |
| Q1 2020 | $2,595,000 | +275.0% | 38,537 | +369.3% | 0.01% | +500.0% |
| Q4 2019 | $692,000 | +8.6% | 8,211 | -3.6% | 0.00% | 0.0% |
| Q3 2019 | $637,000 | -86.6% | 8,520 | -88.7% | 0.00% | -85.7% |
| Q2 2019 | $4,759,000 | +1236.8% | 75,263 | +918.4% | 0.01% | +600.0% |
| Q1 2019 | $356,000 | -8.5% | 7,390 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $389,000 | +88.8% | 7,430 | +12.7% | 0.00% | – |
| Q2 2018 | $206,000 | – | 6,590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 115,479 | $7,302,000 | 11.05% |
| HARTLINE INVESTMENT CORP/ | 335,585 | $21,219,000 | 5.07% |
| Darsana Capital Partners LP | 1,500,000 | $94,845,000 | 3.08% |
| Rhenman & Partners Asset Management AB | 365,899 | $23,136,000 | 2.55% |
| COURAGE CAPITAL MANAGEMENT LLC | 20,000 | $1,265,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 46,599 | $2,946,000 | 2.04% |
| Granite Investment Partners, LLC | 411,659 | $26,029,000 | 1.40% |
| Nicholas Investment Partners, LP | 146,106 | $9,238,000 | 0.85% |
| Baillie Gifford | 8,829,449 | $558,287,000 | 0.59% |
| Cortina Asset Management, LLC | 141,352 | $8,938,000 | 0.55% |